Literature DB >> 14964340

A survey of dentists in the United States regarding a specialty in craniofacial pain.

H Clifton Simmons1, Steven R Kilpatrick.   

Abstract

In an effort to explore whether a specialty for craniofacial pain is warranted, the American Academy of Craniofacial Pain (AACP) commissioned an opinion survey of dentists. The survey population (N=4000) was stratified by specialty, so that dentists in affected areas would be adequately represented: 500 orthodontists and dentofacial orthopedists, 500 oral and maxillofacial surgeons, 500 periodontists, 500 prosthodontists, and 2,000 general practitioners. A total of 930 dentists responded for a 23.2% response rate. The survey had multiple purposes: 1. to measure the percentage of craniofacial pain patients perceived in dental patient populations; 2. to determine whether each dentist prefers to treat the disorder or; 3. prefers to refer craniofacial pain patients to clinicians specializing in the disorder; and 4. whether dentists favor/oppose the formation of a craniofacial pain specialty. The respondents' perception of the prevalence of craniofacial pain among their patients was 13.9%. A majority of the responding dentists, 54.7%, are in favor of a craniofacial pain specialty. Overall, 65% of dentists treat craniofacial pain patients, although more than half, 55%, of all dentists also refer such patients. Even 43.6% of dentists who regularly treat craniofacial pain favor a specialty, while 76% of those who do not treat such patients favor the specialty. The data presented here advocate development of a dental specialty in craniofacial pain.

Entities:  

Mesh:

Year:  2004        PMID: 14964340     DOI: 10.1179/crn.2004.009

Source DB:  PubMed          Journal:  Cranio        ISSN: 0886-9634            Impact factor:   2.020


  1 in total

1.  Management of temporomandibular disorders by Ministry of Public Health dentists in Central Thailand.

Authors:  Supang Chanton; Supranee Vicheinnet; Chanchai Hosanguan; Wantanee Mutirangura
Journal:  Int Dent J       Date:  2017-03-24       Impact factor: 2.607

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.